Key result
Higher pulmonary artery effective elastance in ≥moderate TR is linked to ~55% higher 5-year mortality.
Why the study?
The interaction between the pulmonary artery circulation and the right ventricle and its association with outcomes is incompletely understood, and whether PA Ea discriminates mortality risk in significant TR was unknown.
Does higher pulmonary artery effective elastance (PA Ea) predict mortality in patients with ≥moderate tricuspid regurgitation?
Cohort (n=12,682)
Does higher pulmonary artery effective elastance (PA Ea) predict mortality in patients with ≥moderate tricuspid regurgitation?
Effect estimate: HR 1.55 (95% CI 1.51-1.60)
p-value: p=<0.0001
In patients with significant tricuspid regurgitation, higher echo-derived pulmonary artery effective elastance is independently associated with increased 5-year all-cause mortality.
AIMS: Tricuspid valve regurgitation (TR) is common and associated with increased mortality. The interaction between the pulmonary artery (PA) circulation and the right ventricle (RV) and association with outcomes is incompletely understood. The effective PA elastance (PA Ea) is a composite measure of RV afterload that refers to the pulmonary vascular load that the RV must overcome to eject blood. Whether PA Ea discriminates mortality risk in unselected patients with significant TR is unknown. METHODS AND RESULTS: In consecutive patients with ≥moderate TR, we compared all-cause mortality at 5 years based on the PA Ea (defined as the RV systolic pressure/stroke volume as measured by transthoracic echocardiography). In a total of 12 682 patients, the median PA Ea was 0.7 mm Hg/mL (interquartile range 0.5, 0.9). Increasing levels of PA Ea were associated with heart failure, liver and kidney disease, and clinical markers of risk such as the Tricuspid Regurgitation Impact on Outcomes score. Increasing levels of PA Ea were associated with larger RVs, worse RV systolic function, higher N-terminal pro-brain natriuretic peptide levels, and greater degrees of right heart failure. After adjusting for age and sex, PA Ea was associated with higher risk of death (hazard ratio 1.55 per 0.5 mm Hg/mL change of PA Ea; 95% confidence intervals 1.51-1.60; P < 0.0001). In multivariable modelling incorporating available clinical variables, PA Ea was independently predictive of outcome compared with other indexes of RV-PA coupling. CONCLUSION: In patients with significant TR, higher PA Ea is progressively associated with RV dysfunction, right heart failure, and worse survival. Incorporating PA Ea into the routine echo assessment may help stratify risk.
No takes yet. Share an insight, caveat, or question.
Kane et al. (2025) conducted a cohort in Tricuspid valve regurgitation (n=12,682). Pulmonary artery effective elastance (PA Ea) was evaluated on All-cause mortality (HR 1.55, 95% CI 1.51-1.60, p=<0.0001). Higher pulmonary artery effective elastance in patients with ≥moderate tricuspid regurgitation was associated with increased 5-year all-cause mortality (HR 1.55; 95% CI 1.51-1.60; P<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: